News Sentiment

XBIO sentiment intelligence

Xenetic Biosciences Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 45 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 2.74 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

76/100 classification confidence.

Company focus 37

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

-1.3% over one week, -14.5% over four weeks, trend active, and below fair value.

Latest direct headline Neutral

Price to book forward of Xenetic Biosciences, Inc. – NASDAQ:XBIO

Market Reaction

Balanced read

61/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 76/100 classification
One-week reaction -1.3% Price digesting
Trend fit Trend active -14.5% over four weeks
Fair value -22.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 23
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 37
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
TradingKey 8
Market source 5
TradingView 4
Stock Titan 4
dars.gov.et 3
Finviz 3
simplywall.st 2
ACCESS Newswire 2

Event Lens

What the news is about

Classified themes
Earnings 21
Market update 19
Analyst action 2
Regulatory and legal 2
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-45 of 45